@article{7e2dcd0391684352b45591a355346ee3,
title = "Initial United States experience with the Paracor HeartNet myocardial constraint device for heart failure",
author = "Klodell, \{Charles T.\} and McGiffin, \{David C.\} and Rayburn, \{Barry K.\} and Benjamin Sun and Abraham, \{William T.\} and Conte, \{John V.\} and Russell, \{Stuart D.\} and Pae, \{Walter E.\} and Boehmer, \{John P.\} and Aranda, \{Juan M.\}",
note = "ObjectiveThis study was undertaken to review the initial results and surgical safety data for the US Food and Drug Administration safety and feasibility trial of the Paracor HeartNet (Paracor Medical, Inc, Sunnyvale, Calif.) myocardial constraint device.MethodsPatients with New York Heart Association functional class II or III heart failure underwent device implantation (n = 21) through a left minithoracotomy.ResultsThe average age was 53 years (31-72 years).",
year = "2007",
month = jan,
day = "1",
doi = "10.1016/J.JTCVS.2006.08.070",
language = "American English",
volume = "133",
journal = "The Journal of Thoracic and Cardiovascular Surgery",
number = "1",
}